BioCentury
ARTICLE | Company News

Supernus, Endo deal

November 9, 2015 8:00 AM UTC

Supernus granted Endo’s Par Pharmaceutical company rights to sell the generic version of Trokendi XR topiramate starting on April 1, 2025, settling patent litigation. Par had submitted an ANDA for ap...